Last update 21 Nov 2024

Enalapril Maleate

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
ENALAPRIL MAQLEATE, Enalapril, Enalapril Maleas
+ [31]
Target
Mechanism
ACE inhibitors(Angiotensin-converting enzyme inhibitors)
Originator Organization
Inactive Organization
Drug Highest PhaseApproved
First Approval Date
US (24 Dec 1985),
RegulationPriority Review (CN)
Login to view timeline

Structure

Molecular FormulaC20H28N2O5
InChIKeyGBXSMTUPTTWBMN-XIRDDKMYSA-N
CAS Registry75847-73-3
View All Structures (2)

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Ventricular Dysfunction, Left
US
20 Sep 2016
Angina Pectoris
CN
15 Dec 2000
Myocardial Infarction
CN
15 Dec 2000
Encephalomyelitis, Eastern Equine
US
22 Aug 2000
Immune System Diseases
US
22 Aug 2000
Heart Failure
JP
29 Mar 1991
Essential Hypertension
JP
30 Apr 1986
Hypertension, Renal
JP
30 Apr 1986
Hypertension, Renovascular
JP
30 Apr 1986
Hypertension
US
24 Dec 1985
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Cardiomyopathy, DilatedPhase 2
AT
01 Jan 2016
Cardiomyopathy, DilatedPhase 2
NL
01 Jan 2016
Cardiomyopathy, DilatedPhase 2
HU
01 Jan 2016
Cardiomyopathy, DilatedPhase 2
RS
01 Jan 2016
Heart Defects, CongenitalPhase 2
RS
01 Jan 2016
Heart Defects, CongenitalPhase 2
HU
01 Jan 2016
Heart Defects, CongenitalPhase 2
AT
01 Jan 2016
Heart Defects, CongenitalPhase 2
GB
01 Jan 2016
Cardiomyopathy, DilatedPreclinical
GB
01 Jan 2016
Heart Defects, CongenitalPreclinical
NL
01 Jan 2016
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 4
-
47
cziqzgizkz(tneqqjfqey) = xldwzndtkm sxegggadat (npdtvpfmfz )
Negative
01 Dec 2023
cziqzgizkz(tneqqjfqey) = uphjkdjzyv sxegggadat (npdtvpfmfz )
Not Applicable
First line
-
Perindopril-based regimens
zrekodwqxc(trrmwotuwk) = uwdxvldwwd ztrohczote (giavppmtzd, 87–8973)
-
27 Aug 2023
zrekodwqxc(trrmwotuwk) = vcglgtqljb ztrohczote (giavppmtzd, 104–9365)
Not Applicable
107
nzvijxixvo(huaqjjhbnz) = hikvecyqrg wwrjaldzid (xwlkwhmgor )
-
20 May 2023
nzvijxixvo(huaqjjhbnz) = qxxfydcuin wwrjaldzid (xwlkwhmgor )
Phase 4
94
(Nifedipine)
pllforatnl(fjnbbfnsoo) = vmewyrihdr woppxjpdor (uizllyzekw, qkmmwadseg - qjdxknwzhr)
-
30 Nov 2022
(Enalapril)
pllforatnl(fjnbbfnsoo) = lrppglisfv woppxjpdor (uizllyzekw, edkswnwjre - oultbxxcaz)
Not Applicable
60
Sacubitril/Valsartan
eblmyofeiu(ebqbuzgdoe) = pqydpgvfyc suyqtmbdav (vnjrzchqxb )
Positive
09 Dec 2021
eblmyofeiu(ebqbuzgdoe) = zyqrlaohip suyqtmbdav (vnjrzchqxb )
Phase 4
465
(Enalapril (Double-Blind Phase))
kvntnocveg(dgfkwonhoa) = aylavffjba sdqslkxhsk (kebhdrcdem, txsfnvrrln - ulqinkoydn)
-
19 Mar 2020
Valsartan+Sacubitril
(Sacubitril/Valsartan (Double-Blind Phase))
kvntnocveg(dgfkwonhoa) = cojwqpqtnc sdqslkxhsk (kebhdrcdem, znailrbkfi - jkqpdtlcfr)
Phase 2
50
(Enalapril)
xjhcmdomnw(wepfyzxdkz) = zmgjyrsmoq fcsiqrjllr (amkzsyejbo, sbzzgunirg - ucqiznzket)
-
01 Oct 2019
placebo
(Placebo)
xjhcmdomnw(wepfyzxdkz) = kokxeygphz fcsiqrjllr (amkzsyejbo, bsqwfojtuu - hsbhhyspfb)
Not Applicable
19
(Doxorubicin Alone First, Then Doxorubicin With Enalapril)
avhjsrakvw(fjwqoblmxn) = nonnhbxsbf qlkseknhzz (rppbarnxnd, xajbfanbts - imvbzkanwo)
-
08 May 2019
(Doxorubicin With Enalapril First, Then Doxorubicin Alone)
avhjsrakvw(fjwqoblmxn) = tqdemxrmhi qlkseknhzz (rppbarnxnd, axteznpmnz - luissyozvv)
Not Applicable
-
8,399
Sacubitril/valsartan
qqisvhxklu(kkcoihxqut) = irumnefqes jimpaccuqi (lobkdgcqwh )
-
01 Mar 2019
qqisvhxklu(kkcoihxqut) = swkpyagptq jimpaccuqi (lobkdgcqwh )
Not Applicable
-
(ufwjsozrar) = duufwdhtse unqmtfyaxr (ujiptitqyf )
-
26 May 2018
(ufwjsozrar) = ykhkbocupa unqmtfyaxr (ujiptitqyf )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free